Atlas Trials

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma

Clinical trial NCT03269552 · TERMINATED

Trial details

NCT number
NCT03269552
Sponsor
University of Washington
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Marginal Zone LymphomaRecurrent Marginal Zone LymphomaRecurrent Waldenstrom MacroglobulinemiaRefractory Marginal Zone LymphomaRefractory Waldenstrom MacroglobulinemiaWaldenstrom Macroglobulinemia
Start date
2017-12-18
Primary completion
2018-12-28
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.